AI assistant
BELDEN INC. — Director's Dealing 2025
Dec 8, 2025
31053_dirs_2025-12-08_cd53547e-4006-4ce7-b9c3-b9fcbe36e27a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2025-12-04
Reporting Person: Lieser Brian (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-04 | Common Stock | M | 2516 | $53.79 | Acquired | 31590 | Direct |
| 2025-12-04 | Common Stock | D | 1759 | $120.695 | Disposed | 29831 | Direct |
| 2025-12-04 | Common Stock | M | 1210 | $74.91 | Acquired | 31041 | Direct |
| 2025-12-04 | Common Stock | D | 961 | $120.695 | Disposed | 30080 | Direct |
| 2025-12-04 | Common Stock | M | 1225 | $72.73 | Acquired | 31305 | Direct |
| 2025-12-04 | Common Stock | D | 961 | $120.695 | Disposed | 30344 | Direct |
| 2025-12-05 | Common Stock | S | 1270 | $120 | Disposed | 29074 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-04 | Stock Appreciation Rights | $74.91 | M | 1210 | Disposed | 2027-02-22 | Common Stock (1210) | Direct |
| 2025-12-04 | Stock Appreciation Rights | $72.73 | M | 1225 | Disposed | 2028-02-28 | Common Stock (1225) | Direct |
| 2025-12-04 | Stock Appreciation Rights | $53.79 | M | 2516 | Disposed | 2032-02-22 | Common Stock (2516) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 505.1454 | Indirect |
Footnotes
F1: The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
F2: Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
F3: This represents the difference between the number of SARs exercised (2,516) and the number of shares issued as a result of the exercise (757). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
F4: This represents the difference between the number of SARs exercised (1,210) and the number of shares issued as a result of the exercise (249). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($74.91). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
F5: This represents the difference between the number of SARs exercised (1,225) and the number of shares issued as a result of the exercise (264). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($72.73). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
F6: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
F7: The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.